ArticleAnalytical and bioanalytical chemistry2025
Novel spectrophotometric approaches for analysis of solifenacin and silodosin in pharmaceutical preparations, human plasma, and environmental water samples: assessment of the methods' greenness and practicality.
Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Eco-friendly cucurbituril-based potentiometric sensors for selective quantification of ipratropium bromide in pharmaceuticals and human plasma.Analytical and bioanalytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The recent approval of a fixed-dose combination of silodosin (SOD) and solifenacin succinate (SOF) for overactive bladder syndrome has created a need for innovative analytical approaches enabling their simultaneous quantification. In this work, seven novel, eco-friendly, and cost-efficient spectrophotometric methods were developed for the concurrent determination of SOD and SOF. These methods overcome the limitations of conventional techniques by eliminating the need for complex instrumentation, labor-intensive procedures, and large volumes of hazardous organic solvents, offering a sustainable and accessible analytical alternative. A direct UV method (Method I) enabled selective quantification of SOD at 270 nm (1.0-15.0 μg/mL) with complete spectral independence from SOF. Given the substantial overlap between SOD and SOF spectra, six advanced UV-based methods including dual-wavelength, first derivative, ratio spectra difference, first derivative of ratio spectra, ratio subtraction, and absorption factor were innovatively applied for the accurate quantification of SOF (1.0-12.0 μg/mL). The applicability of the proposed methods was demonstrated through accurate analysis of SOD and SOF in combined pharmaceutical formulations and spiked human plasma, with no interference from excipients or endogenous compounds. The proposed methods were designed to be multifunctional, allowing their application in various analytical settings. They were successfully validated and applied for the quality control analysis of co-formulated pharmaceutical tablets, determination of SOD in spiked human plasma for biological use, and for environmental monitoring in different water matrices. This broad applicability highlights the methods' versatility, robustness, and practical value in routine laboratory analysis. Furthermore, their performance in environmentally relevant aqueous samples underscored their sensitivity and robustness, yielding excellent recovery rates and low %RSD values. Method greenness and practicality were critically evaluated using the GAPI, AGREE, and the recently introduced CACI tool, all confirming the exceptional eco-friendliness and economic viability of the approaches. Full compliance with ICH Q2(R2) guidelines further affirms their validity for routine quality control and environmental monitoring.
Indexed as
Identifiers
40903563What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.